Haemonetics Corp. (HAE) announced a definitive agreement under which the company would acquire Global Med for approximately $60 million in a cash tender offer. The company would fund the acquisition from available cash and anticipates that it would continue to have more than $100 million in cash on the balance sheet at fiscal year end.
As per the terms of the deal, Haemonetics would begin a tender offer to buy all outstanding shares of Global Med's common stock at $1.22 per share and preferred stock at about $1,694 per share. Haemonetics expects the transaction to close in its fourth quarter fiscal 2010.
Additionally, the company tightened its fiscal 2010 guidance ranges to 8% - 9% revenue growth from 8% - 11% and earnings per share in a range of $2.80 - $2.85 compared with its prior range of $2.75 - $2.85. On average, 12 analysts polled by Thomson Reuters expected earnings per share of $2.82 for the quarter. Analysts' estimate typically excludes one-time items.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.